Not applicableActive Not RecruitingNCT00898456What this trial is testingMultidrug Resistance Genes in Patients With Acute Myeloid LeukemiaWho this might be right forLeukemia Alliance for Clinical Trials in Oncology 600
Testing effectiveness (Phase 2)Study completedNCT00602771What this trial is testingTipifarnib and Etoposide in Treating Older Patients With Newly Diagnosed, Previously Untreated Acute Myeloid LeukemiaWho this might be right forAcute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic SyndromeAdult Acute Megakaryoblastic Leukemia (M7)Adult Acute Minimally Differentiated Myeloid Leukemia (M0)+14 more National Cancer Institute (NCI) 84
Large-scale testing (Phase 3)Study completedNCT00052299What this trial is testingChemotherapy With or Without Gemtuzumab Ozogamicin in Treating Older Patients With Acute Myeloid LeukemiaWho this might be right forLeukemia European Organisation for Research and Treatment of Cancer - EORTC 472
Early research (Phase 1)Ended earlyNCT01159301What this trial is testingEntinostat and Sorafenib Tosylate in Treating Patients With Advanced or Metastatic Solid Tumors or Refractory or Relapsed Acute Myeloid LeukemiaWho this might be right forAdult Acute Basophilic LeukemiaAdult Acute Eosinophilic LeukemiaAdult Acute Megakaryoblastic Leukemia (M7)+16 more National Cancer Institute (NCI) 44
Early research (Phase 1)Study completedNCT00470197What this trial is testingFlavopiridol, Cytarabine, and Mitoxantrone in Treating Patients With Relapsed or Refractory Acute LeukemiaWho this might be right forAdult Acute Megakaryoblastic Leukemia (M7)Adult Acute Minimally Differentiated Myeloid Leukemia (M0)Adult Acute Monoblastic Leukemia (M5a)+13 more National Cancer Institute (NCI) 35
Testing effectiveness (Phase 2)Study completedNCT00528398What this trial is testingIdarubicin and High-Dose Cytarabine in Treating Patients With Acute Myeloid LeukemiaWho this might be right forLeukemia City of Hope Medical Center 111
Large-scale testing (Phase 3)Study completedNCT00006363What this trial is testingCombination Chemotherapy With or Without PSC 833, Peripheral Stem Cell Transplantation, and/or Interleukin-2 in Treating Patients With Acute Myeloid LeukemiaWho this might be right forAdult Acute Basophilic LeukemiaAdult Acute Eosinophilic LeukemiaAdult Acute Erythroid Leukemia (M6)+30 more National Cancer Institute (NCI) 720
Early research (Phase 1)Study completedNCT01127009What this trial is testingBortezomib, Mitoxantrone, Etoposide, and Cytarabine in Relapsed or Refractory Acute Myeloid LeukemiaWho this might be right forAdult Acute Megakaryoblastic Leukemia (M7)Adult Acute Minimally Differentiated Myeloid Leukemia (M0)Adult Acute Monoblastic Leukemia (M5a)+12 more Case Comprehensive Cancer Center 3
Testing effectiveness (Phase 2)Study completedNCT00004215What this trial is testingLeridistim Compared With Filgrastim in Treating Older Patients With Acute Myeloid LeukemiaWho this might be right forAnemiaLeukemiaNeutropenia+1 more Memorial Sloan Kettering Cancer Center
Large-scale testing (Phase 3)UnknownNCT00006045What this trial is testingCombination Chemotherapy With or Without Monoclonal Antibody Therapy in Treating Patients With Refractory or Relapsed Acute Myelogenous LeukemiaWho this might be right forLeukemia Facet Biotech
Testing effectiveness (Phase 2)Study completedNCT00002768What this trial is testingChemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Acute Myeloid Leukemia in Second RemissionWho this might be right forLeukemia Alliance for Clinical Trials in Oncology 51
Large-scale testing (Phase 3)Study completedNCT00005863What this trial is testingCombination Chemotherapy With or Without Filgrastim and/or Tretinoin in Treating Patients With Acute Myeloid LeukemiaWho this might be right forLeukemiaMyelodysplastic SyndromesMyelodysplastic/Myeloproliferative Neoplasms Medical Research Council
Testing effectiveness (Phase 2)Study completedNCT00004217What this trial is testingS9918 PSC 833, Daunorubicin, and Cytarabine in Treating Older Patients With Newly Diagnosed Acute Myeloid LeukemiaWho this might be right forLeukemia SWOG Cancer Research Network 55
Not applicableStudy completedNCT01575535What this trial is testingS0106B Studying Bone Marrow Samples From Women With Acute Myeloid LeukemiaWho this might be right forLeukemia SWOG Cancer Research Network 100
Testing effectiveness (Phase 2)Ended earlyNCT02029417What this trial is testingOmacetaxine Mepesuccinate, Cytarabine, and Decitabine in Treating Older Patients With Newly Diagnosed Acute Myeloid LeukemiaWho this might be right forAcute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic SyndromeAdult Acute Megakaryoblastic Leukemia (M7)Adult Acute Minimally Differentiated Myeloid Leukemia (M0)+14 more Roswell Park Cancer Institute 2
Large-scale testing (Phase 3)Study completedNCT00112554What this trial is testingCytarabine With or Without VNP40101M in Treating Patients With Relapsed Acute Myeloid LeukemiaWho this might be right forLeukemia Vion Pharmaceuticals 420
Early research (Phase 1)Study completedNCT00112853What this trial is testingTipifarnib and Etoposide in Treating Older Patients With Newly Diagnosed Acute Myeloid LeukemiaWho this might be right forAdult Acute Megakaryoblastic Leukemia (M7)Adult Acute Minimally Differentiated Myeloid Leukemia (M0)Adult Acute Monoblastic Leukemia (M5a)+12 more National Cancer Institute (NCI) 100
Large-scale testing (Phase 3)Study completedNCT00005823What this trial is testingIntensive Compared With Nonintensive Chemotherapy in Treating Older Patients With Acute Myeloid Leukemia or Myelodysplastic SyndromeWho this might be right forLeukemiaMyelodysplastic SyndromesMyelodysplastic/Myeloproliferative Neoplasms Leukemia Research Fund 2,000
Testing effectiveness (Phase 2)Study completedNCT00066794What this trial is testingS0301 Cyclosporine, Daunorubicin, and Cytarabine in Treating Older Patients With Previously Untreated Acute Myeloid LeukemiaWho this might be right forLeukemia SWOG Cancer Research Network 69
Testing effectiveness (Phase 2)Study completedNCT00425477What this trial is testingBexarotene and GM-CSF in Treating Patients With Myelodysplastic Syndrome or Acute Myeloid LeukemiaWho this might be right forLeukemiaMyelodysplastic SyndromesMyelodysplastic/Myeloproliferative Diseases Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 26